Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.

about

Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract.

P2860

Q46632887-8B110607-F3F9-482B-BDFA-D4F4B9481D58 Q55455104-66ED41AF-B730-4BFB-8FFD-DF63A5986D5A

P2860

Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.

Item

http://www.wikidata.org/entity/Q35712301

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Divide and Conquer May Not Be ...... Nutraceutical Extract, SM6Met.

@ast

Divide and Conquer May Not Be ...... Nutraceutical Extract, SM6Met.

@en

type

Item

label

Divide and Conquer May Not Be ...... Nutraceutical Extract, SM6Met.

@ast

Divide and Conquer May Not Be ...... Nutraceutical Extract, SM6Met.

@en

prefLabel

Divide and Conquer May Not Be ...... Nutraceutical Extract, SM6Met.

@ast

Divide and Conquer May Not Be ...... Nutraceutical Extract, SM6Met.

@en

P1476

Divide and Conquer May Not Be ...... Nutraceutical Extract, SM6Met.

@en

P2093

D de Beer

http://www.w3.org/2001/XMLSchema#string

K Visser

http://www.w3.org/2001/XMLSchema#string

M Mortimer

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1

Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo

Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Estrogen receptor alpha in human breast cancer: occurrence and significance

Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

P304

e0132950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0132950

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Joubert

Ann Louw

P577

2015-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280489141

http://www.w3.org/2001/XMLSchema#string

P698

26208351

http://www.w3.org/2001/XMLSchema#string

P932

4514865

http://www.w3.org/2001/XMLSchema#string

Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.

about

P2860

P2860

Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932